Marieke van Son

82 CHAPTER 4 79. Zamboglou, C.; Rischke, H.C.; Meyer, P.T.; Knobe, S.; Volgeova-Neher, N.; Kollefrath, M.; Jilg, C.A.; Grosu, A.L.; Baltas, D.; Kroenig, M. Single fraction multimodal image guided focal sal- vage high-dose-rate brachytherapy for recurrent prostate cancer. J Contemp Brachytherapy 2016, 8, 241-248; DOI: 10.5114/jcb.2016.61067. 80. Maenhout, M.; Peters, M.; van Vulpen, M.; Moerland, M.A.; Meijer, R.P.; van den Bosch, M.; Nguyen, P.L.; Frank, S.J.; van der Voort van Zyp, J.R.N. Focal mri-guid- ed salvage high-dose-rate brachyther- apy in patients with radiorecurrent prostate cancer. Technology in cancer research & treatment 2017, 16, 1194- 1201; DOI: 10.1177/1533034617741797. 81. Murgic, J.; Morton, G.; Loblaw, A.; D’Al- imonte, L.; Ravi, A.; Wronski, M.; Da- vidson, M.; Haider, M.; Commisso, K.; Zhang, L., et al. Focal salvage high dose- rate brachytherapy for locally recurrent prostate cancer after primary radiation therapy failure: Results from a prospec- tive clinical trial. Int J Radiat Oncol Biol Phys 2018, 102, 561-567; DOI: 10.1016/j. ijrobp.2018.06.039. 82. Jereczek-Fossa, B.A.; Beltramo G.; Fariselli L.; Fodor C.; Santoro L.; Vavas- sori A.; Zerini D.; Gherardi F.; Ascione C.; Bossi-Zanetti I.; Mauro R.; Bregantin A.; Bianchi LC.; De Cobelli O.; Orecchia R. Robotic image-guided stereotactic radiotherapy, for isolated recurrent pri- mary, lymph node or metastatic prostate cancer. International journal of radiation oncology, biology, physics 2012, 82, 889- 897; DOI: 10.1016/j.ijrobp.2010.11.031. 83. Mbeutcha, A.; Chauveinc, L.; Bondiau, P.Y.; Chand, M.E.; Durand, M.; Chevallier, D.; Amiel, J.; Kee, D.L.; Hannoun-Levi, J.M. Salvage prostate re-irradiation using high-dose-rate brachytherapy or focal stereotactic body radiotherapy for local recurrence after definitive radiation therapy. Radiation oncology (London, England) 2017, 12, 49; DOI: 10.1186/ s13014-017-0789-9. 84. Golbari, N.M.; Katz, A.E. Salvage thera- py options for local prostate cancer re- currence after primary radiotherapy: A literature review. Curr Urol Rep 2017, 18, 63; DOI: 10.1007/s11934-017-0709-4. 85. Zdrojowy, R.; Dembowski, J.; Malkiewicz, B.; Tupikowski, K.; Krajewski, W. Salvage local therapy for radiation-recurrent prostate cancer - where are we? Central European journal of urology 2016, 69, 264-270; DOI: 10.5173/ceju.2016.832. 86. Duijzentkunst, D.A.; Peters, M.; van der Voort van Zyp, J.R.; Moerland, M.A.; van Vulpen, M. Focal salvage therapy for local prostate cancer recurrences after prima- ry radiotherapy: A comprehensive review. World journal of urology 2016, 34, 1521- 1531; DOI: 10.1007/s00345-016-1811-9. 87. Eiber, M.; Weirich, G.; Holzapfel, K.; Sou- vatzoglou, M.; Haller, B.; Rauscher, I.; Beer, A.J.; Wester, H.J.; Gschwend, J.; Schwaiger, M., et al. Simultaneous (68) ga-psma hbed-cc pet/mri improves the localization of primary prostate cancer. Eur Urol 2016, 70, 829-836; DOI: 10.1016/j.eururo.2015.12.053. 88. Kaljouw, E.; Pieters, B.R.; Kovacs, G.; Hoskin, P.J. A delphi consensus study on salvage brachytherapy for pros- tate cancer relapse after radiothera- py, a uro-gec study. Radiother Oncol 2016, 118, 122-130; DOI: 10.1016/j. radonc.2015.10.021. 89. Peters, M.; Kanthabalan, A.; Shah, T.T.; McCartan, N.; Moore, C.M.; Arya, M.; van der Voort van Zyp, J.R.; Moerland, M.A.; Hindley, R.G.; Emberton, M., et al. Development and internal validation of prediction models for biochemical fail- ure and composite failure after focal salvage high intensity focused ultra- sound for local radiorecurrent prostate cancer: Presentation of risk scores for individual patient prognoses. Urol Oncol 2018, 36, 13 e11-13 e10; DOI: 10.1016/j. urolonc.2017.08.022.